Niagen Bioscience Cash Flow Statement (2010-2026) | NAGE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Oct2010 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Mar2014 Jun2014 Sep2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-5.57M-8.86M-5.33M-7.74M-6.40M-3.07M-1.44M-1.97M-2.19M-0.96M0.11M-0.49M-0.01M1.88M7.18M5.06M3.61M4.58M4.13M6.32M
Depreciation and Depletion (Quarter)
0.23M0.23M0.21M0.20M0.21M0.23M0.22M0.23M0.23M0.23M0.18M0.18M0.17M0.16M0.15M0.16M0.16M0.16M0.14M0.12M
Share-based Compensation (Quarter)
1.62M1.82M1.47M1.89M1.30M1.23M1.33M1.27M1.32M1.12M1.04M0.98M1.19M0.73M0.75M1.07M1.49M1.76M1.75M1.72M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
0.05M0.00M-0.14M-0.02M-0.02M0.03M-0.06M-0.02M-0.02M-0.02M0.07M0.00M-0.04M-0.02M0.08M-0.00M0.01M-0.01M0.02M
Asset Writedowns and Impairment (Quarter)
0.01M-0.18M0.20M0.01M-0.01M0.02M0.04M0.32M0.40M0.20M0.02M0.04M0.01M0.01M-1.31M-1.32M0.09M-0.01M0.03M0.09M
Non-cash Items (Quarter)
Change in Working Capital (Quarter)
Change in Receivables (Quarter)
1.36M-0.88M0.13M1.09M-2.07M0.52M3.77M1.08M-2.67M-0.32M-0.35M1.41M1.23M-0.71M-0.64M-2.04M2.69M-1.16M1.26M3.41M
Change in Inventory (Quarter)
-0.58M0.49M0.93M1.71M0.45M-0.12M-0.96M-2.77M0.07M0.65M1.90M-2.03M-0.98M-0.97M-1.35M1.99M3.22M4.38M2.04M3.57M
Change in Account Payables (Quarter)
-1.72M0.83M-0.38M-0.64M0.42M-1.08M0.56M-0.73M1.08M-0.83M1.03M-2.33M0.21M-1.20M2.26M2.11M3.05M-0.94M-1.95M2.48M
Change in Accured Expenses (Quarter)
-1.76M0.76M0.15M1.65M-1.43M0.06M0.58M1.27M-0.53M1.11M0.30M0.97M-1.84M0.97M1.11M1.23M-1.67M1.32M0.96M-0.10M
Other Working Capital Changes (Quarter)
-0.10M-0.30M1.28M-0.04M0.06M2.25M-2.72M-0.17M-0.14M-0.15M-0.19M-0.11M-0.21M-0.41M0.78M-0.02M-0.27M-0.09M-0.57M-0.01M
Cash from Operations (Quarter)
-7.89M-5.92M-4.94M-7.20M-3.83M-3.74M-0.33M2.79M3.28M0.40M0.65M0.29M-0.26M3.50M8.58M7.88M1.22M3.73M0.68M-1.19M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.01M0.05M0.05M0.30M0.17M0.17M-0.45M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.06M0.17M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.23M0.23M0.21M0.20M0.21M0.23M0.22M0.23M0.23M0.23M0.18M0.18M0.17M0.16M0.15M0.16M0.16M0.16M0.14M0.12M
Investing Activities
Capital Expenditures (Quarter)
0.27M0.10M0.00M0.03M0.09M0.05M0.17M0.09M0.01M0.03M0.02M0.04M0.01M0.04M0.07M0.03M0.14M0.02M0.10M0.06M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
Divestments (Quarter)
5.80M
Cash from Investing Activities (Quarter)
-0.27M-0.10M-0.00M-0.03M-0.09M-0.05M-0.17M-0.09M-0.01M-0.03M-0.02M-0.04M-0.01M-0.02M-0.07M-0.03M-0.14M-0.02M-0.10M5.25M
Financing Activities
Other financing activities (Quarter)
0.00M0.06M0.01M0.06M0.07M0.01M0.04M0.01M0.01M0.06M
Cash from Financing Activities (Quarter)
2.25M0.34M0.06M-0.00M-0.00M-0.02M7.68M-0.00M-0.01M-0.00M-0.08M-0.01M0.60M1.04M3.75M3.10M3.74M0.15M-0.08M-2.29M
Additional items
Change in Cash (Quarter)
-5.91M-5.68M-4.88M-7.23M-3.92M-3.81M7.18M2.70M3.27M0.37M0.55M0.24M0.32M4.51M12.26M10.96M4.86M3.82M0.50M1.76M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
-8.16M-6.01M-4.95M-7.22M-3.92M-3.79M-0.50M2.70M3.27M0.37M0.63M0.25M-0.28M3.45M8.51M7.85M1.08M3.70M0.58M-1.25M
Net Cash Flow (Quarter)
-5.91M-5.68M-4.88M-7.23M-3.92M-3.81M7.18M2.70M3.27M0.37M0.55M0.24M0.32M4.51M12.26M10.96M4.83M3.85M0.50M1.76M